Home › Funds › Caption Management, LLC › GSK
Caption Management, LLC position in GSK
GSK PLC ADR F · Health Care
Caption Management, LLC reported holding 658,000 shares of GSK (GSK PLC ADR F) in its Q2 2026 13F filing — a position valued at US$34.5M, representing 0.59% of its reported portfolio and ranking #36 among its reported holdings. Caption Management, LLC has disclosed GSK holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Caption Management, LLC's GSK position evolved
Caption Management, LLC first disclosed a stake in GSK in Q3 2023 at 5,000 shares (US$181K). The position peaked in Q2 2026 at 658,000 shares, worth US$34.5M. Across 5 filings, Caption Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 658,000 shares valued at US$34.5M. Notable position changes include a 650% increase in Q3 2024 (shares fell 17% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 5.00K | $181.25K | New |
| Q4 2023 | 5.00K | $185.30K | Hold |
| Q2 2024 | 20.00K | $770.00K | New |
| Q3 2024 | 150.00K | $6.13M | Add |
| Q2 2026 | 658.00K | $34.49M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GSK and 13F data
GSK (GSK PLC ADR F) is a Health Care company. 23 other funds we track also report a position in GSK — the largest reported positions include Dodge & Cox (US$2.53B), DODGE & COX (US$2.53B), PRIMECAP MANAGEMENT CO/CA/ (US$1.32B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GSK
- Dodge & Cox 48.20M sh · $2.53B · Q2 2026
- DODGE & COX 48.20M sh · $2.53B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 25.18M sh · $1.32B · Q2 2026
- JTC Employer Solutions Trustee Ltd 8.59M sh · $450.31M · Q2 2026
- Mondrian Investment Partners LTD 4.97M sh · $239.21M · Q3 2026
- Grantham, Mayo, Van Otterloo & Co. LLC 3.60M sh · $188.69M · Q2 2026
- EQUITY INVESTMENT CORP 3.27M sh · $171.40M · Q2 2026
More on Caption Management, LLC
FAQ
How long has Caption Management, LLC held GSK?
Caption Management, LLC has disclosed GSK holdings in 5 of the last 12 reported quarters, going back to Q3 2023.
What is Caption Management, LLC's current position in GSK?
As of Q2 2026, Caption Management, LLC holds 658.00K shares of GSK (GSK PLC ADR F), valued at $34.49M, representing 0.59% of its reported portfolio and ranking #36.
Has Caption Management, LLC been buying or selling GSK?
In the latest 13F filing (Q2 2026), Caption Management, LLC newly opened its position in GSK. The position peaked in Q2 2026 at 658.00K shares.
Which other funds hold GSK?
Other major institutional holders of GSK include Dodge & Cox, DODGE & COX, PRIMECAP MANAGEMENT CO/CA/, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.